Greater China
-
ArriVent in Newtown Square Sees Big Potential in New Cancer Drug
ArriVent BioPharma in Newtown Square is working on a deal potentially worth more than $1 billion to acquire the rights for an experimental gastrointestinal cancer…
Greater China

ArriVent BioPharma in Newtown Square is working on a deal potentially worth more than $1 billion to acquire the rights for an experimental gastrointestinal cancer…